Abu Dhabi, UAE, February 2: Presight AI, a G42 company, and the region’s international leader in Big Data Analytics powered by AI , has signed an MOU with G42 Healthcare, the leading AI health-tech company based in Abu Dhabi, to develop a foundational big data model.
Leveraging Presight’s omni-analytics platform and G42 Healthcare’s in-depth knowledge and expertise in the health industry, the collaboration will result in the exploration of population health management, wellness and performance data prediction, and time-sequenced events and behavioral analysis prediction.
The agreement was signed at Arab Health Week by Dr. Adel Al Sharji, Chief Operating Officer of Presight AI, and Ashish Koshy, Chief Executive Officer of G42 Healthcare.
The new collaboration will transform the analytical capability of both government entities and hospitals, improving record collection and understanding advanced digitized processes, such as optical character recognition (OCR) and natural language processing (NLP) used in the healthcare industry. This eases administrative practices, improves data accuracy, and reduces manual data entry. Additionally, machine-learning-based models will help unlock insights about patient demographics, health issues, diagnoses, and hospital and clinic resource utilization.
By combining data collected from smartwatches, wristbands, and advanced omics applications, organizations will advance personal health analytics with the goal of improving the early detection of health issues and provide recommendations on necessary dietary methods, sleeping schedules, and exercise plans for optimal health. In addition, the collaboration between Presight and G42 Healthcare will provide a wellness and performance management platform for athletes, guiding their dietary and training programs to enhance physical performance.
Commenting on the collaboration, Dr. Adel Al Sharji, Chief Operating Officer of Presight AI, said: “At Presight, we are committed to leveraging the power of big data analytics powered by AI to drive the digital transformation across industries. This partnership with G42 Healthcare is the perfect example of how we are putting this commitment into action. The combined knowledge of both organizations has a significant positive impact by extending the quality of care provided in the region and creating new verticals in the healthcare industry led by data-driven insights.”
Ashish Koshy, Chief Executive Officer of G42 Healthcare, said: “The collaboration between G42 Healthcare and Presight AI is expanding the horizons of the healthcare industry, and will have a positive impact on transforming lives and making a real difference to health and well-being of people across the region”
Presight AI, a G42 company, is the region’s leading big data analytics company powered by AI. It combines technology, data, and people to answer real-world challenges with progressive solutions in every sector and at any scale. With its world-class computer vision, Artificial Intelligence (“AI”) and omni-analytics platform as its engine, Presight leverages multi-source data to support insight-driven decision making that shapes policy and creates safer, healthier, happier, and more sustainable societies.
About G42 Healthcare
G42 Healthcare, a leading health-tech company, is on a mission to develop a world-class healthcare sector in the UAE and beyond, by harnessing data and advanced medical technologies to unlock the potential of personalized and preventive care and transforming the traditional healthcare ecosystem. We have built Biogenix Labs, UAE’s first COVID-19 accredited large-scale throughput laboratory, facilitated the 4Humanity clinical trials, the world’s first phase three trial for inactivated vaccine against COVID-19 with over 43,000 volunteers from 125+ nationalities across the pan-Arab region, established the region’s first dedicated contract research organization (IROS) for conducting clinical research with and for local populations, supported UAE’s healthcare authorities on the national vaccination implementation, conducted research into new vaccines and drug therapies, and built Omics Centre of Excellence, the region’s largest and most technologically advanced Omics facility that is the backbone for the Emirati Genome Program, the world’s most comprehensive population genomics initiative.